Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
金曜日, 8 28

Propanc Biopharma Inc

PPCBNASDAQ
Trade with Public
Trade with Public
$1.35
-0.88-39.46%
近くで: Aug 28, 5:00 PM EST
$1.35
N/A
時間外: 5:53 PM EST
PRO
なぜ動いているのか？:Propanc Biopharma shares are trading higher after the company announced pre...
概要ニュース業績予想財務センチメント比較株式レポート

Propanc Biopharma Earnings & Forecasts

Propanc Biopharma (PPCB) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Propanc Biopharma Guidance

Recent Earnings Results

MetricQ3 '26Q2 '26Q1 '26
Earnings Per Share (Non-GAAP)
Estimate———
Actual$-7.00$-7.50$-9.75
Surprise———
Revenue
Estimate———
Actual$0$0$0
Surprise———

Earnings & Guidance News

PRO
Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 percent increase over losses of $(12.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q2 EPS $(0.30) Up From $(32.23) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.30) per share. This is a 99.07 percent increase over losses of $(32.23) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q1 2025 EPS $(0.39) Up From $(35.97) YoY

Benzinga Newsdesk

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

Avi Kapoor

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved